Report error Found 216 with Last Name = 'serafimova' and Initial = 'i'
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 2nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 2.40nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK2/Cyclin A (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 3nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 3nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 3.60nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 3.80nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
Affinity DataIC50: 4nMAssay Description:Inhibition of CDK9/Cyclin T (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 4nMAssay Description:Inhibition of CDK9/Cyclin T (unknown origin)More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 4.5nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 4.70nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 4.80nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
Affinity DataIC50: 5nMAssay Description:Inhibition of CDK2/Cyclin A (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 5nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 6.5nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 7nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
Affinity DataIC50: 7nMAssay Description:Inhibition of CDK2/cyclin A by IMAP florescence polarization assayMore data for this Ligand-Target Pair
Affinity DataIC50: 9nMAssay Description:Inhibition of CDK2/cyclin A by IMAP florescence polarization assayMore data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 10.5nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 12.6nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 13nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 13.2nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 14nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 14nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Inhibition of CDK2/Cyclin A (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 14.8nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:Inhibition of CDK2/Cyclin A (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 17nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:Inhibition of CDK2/Cyclin A (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Inhibition of CDK2/cyclin A by IMAP florescence polarization assayMore data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Inhibition of CDK2/Cyclin A (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Inhibition of CDK2/Cyclin A (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 20.9nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 23.2nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 24.3nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 26.1nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
Affinity DataIC50: 28nMAssay Description:Inhibition of CDK2/cyclin A by IMAP florescence polarization assayMore data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 30.4nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
Affinity DataIC50: 36nMAssay Description:Inhibition of CDK2/Cyclin A (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
Affinity DataIC50: 38nMAssay Description:Inhibition of CDK2/cyclin A by IMAP florescence polarization assayMore data for this Ligand-Target Pair
3D Structure (crystal)Affinity DataIC50: 40nMAssay Description:Inhibition of CDK9/cyclinT by IMAP florescence polarization assayMore data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 40nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
Affinity DataIC50: 40nMT: 25°CAssay Description:Btk (human, full length) was purchased (Invitrogen, catalog number PV3363) and used as specified in the product literature. Btk (2 nM final concentra...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 41nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 41.3nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
TargetRibosomal protein S6 kinase alpha-3 [399-740](Human)
The Regents of The University of California
US Patent
The Regents of The University of California
US Patent
Affinity DataIC50: 41.3nMpH: 8.0 T: 22°CAssay Description:RSK2 CTD and His6-ERK2 were expressed and purified as described (Cohen et al., Science, 308: 1318). The C436V mutant of RSK2 CTD was generated by Qui...More data for this Ligand-Target Pair
Affinity DataIC50: 46nMAssay Description:Inhibition of CDK2/Cyclin A (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
Affinity DataIC50: 62nMAssay Description:Inhibition of CDK7/cyclinH by IMAP florescence polarization assayMore data for this Ligand-Target Pair
Affinity DataIC50: 62nMAssay Description:Inhibition of CDK7/Cyclin H (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 70nMT: 25°CAssay Description:Btk (human, full length) was purchased (Invitrogen, catalog number PV3363) and used as specified in the product literature. Btk (2 nM final concentra...More data for this Ligand-Target Pair
